Skip to main content
Skip to main content
BYAH logo

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH)

$0.74 $-0.10 (-11.71%) |CouncilHOLD · 50 · B
Bottom line: HOLD — our Council read (50/100) and AI Score (50/100) broadly agree.
MCap: 501K| Vol: 15.73M| 52-wk range: $0.93 – $2074.50
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) trades at $0.74 with AI Score 50/100 (Grade B). Park Ha Biological Technology Co. , Ltd. Market cap: $500,642, Sector: Consumer cyclical.

Price live · AI analysis from Mar 17, 2026
Park Ha Biological Technology Co., Ltd. is an investment holding company focused on developing skincare products under the “Park Ha” brand in China. The company operates through subsidiaries involved in direct product sales and franchise services.

Analyst Coverage for BYAH: BYAH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BYAH against Consumer Cyclical peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.

Council Score · Weighted Average of 3 Disciplines
HOLD 50/100 · B

BYAH: the 1 perspectives are evenly split.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) Consumer Business Overview

CEOXiaoqiu Zhang
Employees31
HeadquartersWuxi, CN
IPO Year2025

Park Ha Biological Technology Co., Ltd. is a China-based investment holding company specializing in the development and distribution of skincare products under the “Park Ha” brand. The company operates in the competitive personal care market, utilizing direct sales and franchise models within the People's Republic of China.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Mar 17, 2026

What Is the Investment Thesis for BYAH?

Park Ha Biological Technology Co., Ltd. operates in the attractive Chinese skincare market, evidenced by a high gross margin of 90.6%. However, the company's negative profit margin of -965.0% raises concerns about operational efficiency and cost management. With a market capitalization of 501K and a negative P/E ratio of -0.03, the company's valuation is challenging. Growth catalysts include expanding its franchise network and enhancing its direct sales capabilities. Key risks include intense competition in the skincare market and the company's current lack of profitability. Monitoring the company's ability to improve its bottom line and effectively manage its operational costs is crucial for assessing its long-term viability.

Based on FMP financials and quantitative analysis

BYAH Key Highlights

  • Gross Margin of 90.6% indicates strong pricing power and efficient cost of goods sold.
  • Negative Profit Margin of -965.0% signals significant operational inefficiencies or high operating expenses.
  • Market Cap of 501K reflects the company's small size and potential illiquidity.
  • P/E Ratio of -0.03 indicates the company is currently not profitable.
  • Beta of -3.94 suggests the stock is significantly less volatile than the market, but may also reflect a lack of trading activity.

Who Are BYAH's Competitors?

BYAH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
AZI Autozi Internet Technology (Global) Ltd. $1.82 -2.15% $8.17M 34
BTBD BT Brands, Inc. $1.07 -0.93% $6.62M 34
CGTL Creative Global Technology Holdings Limited $0.32 -8.58% $7.57M 37
DSS DSS, Inc. $0.62 +1.72% $5.26M
ROVR Rover Group, Inc. $10.99 +0.05% $2.00B 62
CVSA Covista Inc. $130.15 +0.20% $4.43B 58
CVSGF CVS Group plc $16.55 +0.00% $1.15B 52
MCW Mister Car Wash, Inc. $7.10 +0.00% $2.34B 51

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are BYAH's Key Strengths?

  • Established brand presence in the Chinese skincare market.
  • Franchise network provides a scalable distribution model.
  • High gross margin indicates strong pricing power.
  • Focus on a specific niche within the consumer cyclical sector.

What Are BYAH's Weaknesses?

  • Negative profit margin indicates operational inefficiencies.
  • Small market capitalization limits access to capital.
  • Limited geographic diversification, relying solely on the Chinese market.
  • High beta suggests potential volatility.

What Could Drive BYAH Stock Higher?

  • Expansion of the franchise network into new regions within China, targeting Tier 2 and Tier 3 cities by Q4 2026.
  • Development and launch of new skincare products catering to specific consumer needs and preferences, with a focus on natural and organic ingredients.
  • Implementation of targeted marketing campaigns and social media strategies to enhance brand awareness and drive customer acquisition.

What Are the Key Risks for BYAH?

  • Intense competition from established domestic and international brands, potentially impacting market share and profitability.
  • Changes in consumer preferences and trends in the skincare market, requiring continuous innovation and adaptation.
  • Regulatory changes and compliance requirements in China, potentially increasing operational costs and complexity.
  • Economic downturns affecting consumer spending on discretionary items, potentially reducing demand for skincare products.

What Are the Growth Opportunities for BYAH?

  • Expanding Franchise Network: Park Ha can grow by expanding its franchise network across China, particularly in Tier 2 and Tier 3 cities where demand for skincare products is increasing. The market size for skincare products in these regions is estimated to reach $50 billion by 2028. By offering attractive franchise terms and providing comprehensive support to franchisees, Park Ha can accelerate its market penetration and increase brand visibility. This expansion can be achieved within the next 3-5 years.
  • Enhancing Direct Sales Capabilities: Investing in its direct sales channels, including online platforms and direct marketing initiatives, can enable Park Ha to reach a broader customer base and improve customer engagement. The e-commerce market for skincare products in China is projected to grow to $80 billion by 2027. By leveraging data analytics and personalized marketing, Park Ha can optimize its direct sales efforts and drive revenue growth. This initiative can be implemented within the next 2 years.
  • Product Innovation and Diversification: Developing new and innovative skincare products that cater to specific consumer needs and preferences can help Park Ha differentiate itself from competitors and capture a larger market share. The demand for specialized skincare products, such as anti-aging and acne treatment solutions, is growing rapidly. By investing in research and development and collaborating with leading dermatologists, Park Ha can launch new products that address unmet consumer needs. This can be an ongoing effort with new products released every 12-18 months.
  • Strengthening Brand Awareness: Implementing targeted marketing campaigns and leveraging social media platforms to enhance brand awareness and build brand loyalty can drive customer acquisition and retention. The use of Key Opinion Leaders (KOLs) and influencers in the beauty industry is highly effective in China. By partnering with popular KOLs and creating engaging content, Park Ha can increase its brand visibility and attract new customers. This is an ongoing opportunity with continuous marketing efforts.
  • Strategic Partnerships and Collaborations: Forming strategic partnerships with complementary businesses, such as beauty salons and spas, can expand Park Ha's distribution channels and reach new customer segments. Collaborating with these businesses can provide Park Ha with access to a wider customer base and enhance its brand image. This initiative can be pursued within the next 1-3 years, focusing on building mutually beneficial relationships.

What Opportunities Does BYAH Have?

  • Expanding the franchise network to new regions within China.
  • Developing new and innovative skincare products.
  • Leveraging e-commerce and social media to enhance direct sales.
  • Forming strategic partnerships with complementary businesses.

What Threats Does BYAH Face?

  • Intense competition from established domestic and international brands.
  • Changing consumer preferences and trends in the skincare market.
  • Regulatory changes and compliance requirements in China.
  • Economic downturns affecting consumer spending on discretionary items.

What Are BYAH's Competitive Advantages?

  • Brand Recognition: The “Park Ha” brand may have some level of recognition within the Chinese market, providing a competitive edge.
  • Franchise Network: The established franchise network provides a distribution advantage and recurring revenue stream.
  • Proprietary Formulations: The company's skincare products may contain unique formulations that differentiate them from competitors.

What Does BYAH Do?

Park Ha Biological Technology Co., Ltd. is an investment holding company that operates in the consumer cyclical sector, specifically within the personal products and services industry. The company focuses on the development, distribution, and sales of skincare products under its proprietary “Park Ha” brand. Headquartered in Wuxi, China, Park Ha conducts its business through subsidiaries that engage in direct product sales and franchise operations. The company's business model emphasizes a direct-to-consumer approach, leveraging franchise networks to expand its market reach across the People's Republic of China. Park Ha aims to cater to the growing demand for skincare products in the Chinese market by offering a range of products designed to meet diverse consumer needs. While the company's history and specific founding details are not provided, its current strategy revolves around strengthening its brand presence and optimizing its distribution channels to enhance profitability and market share in the competitive skincare industry. The company currently employs 31 individuals.

What Products and Services Does BYAH Offer?

  • Develops skincare products under the “Park Ha” brand.
  • Operates as an investment holding company.
  • Engages in direct product sales through its subsidiaries.
  • Provides franchise services to expand its distribution network.
  • Focuses on the Chinese skincare market.
  • Manages a portfolio of skincare products targeting various consumer needs.

How Does BYAH Make Money?

  • Develops and markets skincare products under its own brand.
  • Generates revenue through direct sales of products to consumers.
  • Expands market reach through a franchise model, earning fees and royalties from franchisees.

What Industry Does BYAH Operate In?

The personal products and services industry is characterized by intense competition, evolving consumer preferences, and a constant need for innovation. The Chinese skincare market, in particular, is experiencing substantial growth, driven by increasing disposable incomes and a rising awareness of skincare products. Park Ha Biological Technology Co., Ltd. operates in this dynamic environment, competing with both domestic and international brands. Key trends include the growing popularity of e-commerce, the demand for natural and organic products, and the increasing influence of social media marketing. Companies like AZI, BTBD, CENN, CGTL, and DSS represent some of the competitors in this space, each vying for market share through different product offerings and distribution strategies.

Who Are BYAH's Key Customers?

  • Consumers in the People's Republic of China seeking skincare products.
  • Franchisees who operate Park Ha branded stores and sell products.
  • Customers seeking a range of skincare solutions for different skin types and concerns.
AI Confidence: 69% Updated: Mar 17, 2026

Company Profile

Park Ha Biological Technology Co., Ltd. Ordinary Shares operates in the Personal Products & Services industry within the Consumer Cyclical sector. It is headquartered in Wuxi, CN. The company is led by CEO Xiaoqiu Zhang. BYAH has traded publicly since 2025.

BYAH Revenue & Earnings Trend

In Q4 2025, BYAH generated $1.3M in top-line revenue, marking a sequential increase of 3.7%. The company recorded a net loss of $4.5M, with diluted EPS of $-7.61.

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) Valuation Context

Valued at 501K, BYAH is classified as a micro-cap stock. Relative to its peer group, BYAH's quantitative score of 50/100 is roughly in line with the peer average of 42/100.

Key Financial Metrics

Its free cash flow yield is -0.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.92 indicates the company holds enough short-term assets to cover its near-term obligations.

BYAH Financials

Fundamental Snapshot

Revenue Growth (FY)
+6.0%
Free Cash Flow Growth (FY)
-100.3%
Current Ratio
2.9

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Recent insider buying suggests confidence in the company's future, indicating that key stakeholders believe in its potential growth.
  • Community sentiment has shown a notable uptick, with discussions highlighting the company's innovative approaches in biotechnology.
  • Positive developments in product pipelines have generated excitement among investors, reflecting a growing belief in the company's market position.
  • The overall market perception has shifted favorably, with increased interest in biotech firms, especially those focused on sustainable solutions.

Bear Case

  • Concerns have been raised about regulatory challenges in the biotech sector, which could impede growth and innovation timelines.
  • Some community members express skepticism regarding the scalability of Park Ha's technologies, fearing they may face stiff competition.
  • Recent market volatility has led to cautious sentiment, with investors wary of potential downturns in the biotechnology space.
  • Insider selling activity has also been noted, raising questions about the confidence of some stakeholders in the company's short-term prospects.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q4 2025 $1M -$5M -$7.61
Q2 2025 $1M -$20M -$33.76

Based on FMP financials and quantitative analysis

BYAH Latest News

BYAH Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BYAH.

Price Targets

Wall Street price target analysis for BYAH.

BYAH MoonshotScore

50/100

What does this score mean?

The MoonshotScore rates BYAH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Latest Park Ha Biological Technology Co., Ltd. Ordinary Shares Analysis

Leadership: Xiaoqiu Zhang

CEO

Xiaoqiu Zhang serves as the CEO of Park Ha Biological Technology Co., Ltd., overseeing the company's operations and strategic direction. While specific details regarding Zhang's educational background and previous roles are not available, their leadership is focused on driving growth and profitability within the competitive skincare market in China. Zhang is responsible for managing the company's 31 employees and ensuring the effective execution of its business strategy.

Track Record: As CEO, Xiaoqiu Zhang is responsible for guiding Park Ha Biological Technology Co., Ltd. through the challenges and opportunities of the Chinese skincare market. Specific achievements and milestones under Zhang's leadership are not detailed in the provided information. However, their focus is likely on expanding the company's franchise network, enhancing its direct sales capabilities, and improving its overall financial performance.

Common Questions About BYAH (Consumer Cyclical)

What does Park Ha Biological Technology Co., Ltd. Ordinary Shares do?

Park Ha Biological Technology Co., Ltd. operates as an investment holding company with a focus on developing and distributing skincare products under the “Park Ha” brand in the People's Republic of China. The company conducts its business through subsidiaries involved in direct product sales and franchise services. Its primary focus is on catering to the growing demand for skincare products in the Chinese market by offering a range of products designed to meet diverse consumer needs, leveraging both direct sales and franchise networks for distribution.

What do analysts say about BYAH stock?

As of March 17, 2026, there is no available analyst coverage or consensus rating for Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH). The company's financial metrics, including a negative profit margin and a small market capitalization, may contribute to the lack of analyst coverage. Investors should conduct their own due diligence and consider the company's financial performance, growth prospects, and competitive landscape before making any investment decisions.

What are the main risks for BYAH?

The main risks for Park Ha Biological Technology Co., Ltd. include intense competition in the Chinese skincare market, which is dominated by both domestic and international brands. The company's negative profit margin also poses a significant risk, indicating potential operational inefficiencies or high operating expenses. Additionally, changes in consumer preferences, regulatory requirements, and economic conditions in China could impact the company's performance. The company's small market capitalization also contributes to liquidity risk.

What are the key factors to evaluate for BYAH?

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) holds an AI score of 50/100 (moderate). Not financial advice.

How frequently does BYAH data refresh on this page?

BYAH prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven BYAH's recent stock price performance?

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established brand presence in the Chinese skincare market. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider BYAH overvalued or undervalued right now?

Valuing Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying BYAH?

Before investing in Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Financial data is limited, and the absence of analyst coverage introduces uncertainty.
  • The company's future performance is subject to various risks and uncertainties, including competition, regulatory changes, and economic conditions.
Data Sources

Popular Stocks